|
Volumn 22, Issue 2 B, 2002, Pages 1065-1070
|
Increased expression of integrin β1 is a poor prognostic factor in small-cell lung cancer
a a a a a a a a a a a a a |
Author keywords
Integrin 1; Lung cancer; Prognosis
|
Indexed keywords
BETA1 INTEGRIN;
CARBOPLATIN;
CISPLATIN;
DOXORUBICIN;
ETOPOSIDE;
IRINOTECAN;
TENIPOSIDE;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER STAGING;
DRUG RESPONSE;
FEMALE;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
LUNG SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
SURVIVAL RATE;
TRANSBRONCHIAL BIOPSY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIGENS, CD29;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SMALL CELL;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
GENE EXPRESSION;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
PROGNOSIS;
SURVIVAL RATE;
|
EID: 0036321936
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (35)
|
References (16)
|